Exchange: OTC·Updated 10:31 AM EST

PANC Panacos Pharmaceuticals Inc.

$0.00
$0.00
(0.00%)
Today
Mkt Cap$54.00
Vol120.00

About PANC

Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its product candidate, bevirimat, which works by a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in December 1992 and is headquartered in Watertown, MA.
50

Sentiment

How do you feel about PANC?

Advertisement|Remove ads.